Jacobs Levy Equity Management Inc. increased its holdings in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Free Report) by 50.1% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 533,196 shares of the company's stock after purchasing an additional 177,856 shares during the period. Jacobs Levy Equity Management Inc. owned approximately 0.28% of Aveanna Healthcare worth $2,437,000 at the end of the most recent reporting period.
Several other hedge funds have also recently added to or reduced their stakes in the business. Barclays PLC raised its position in shares of Aveanna Healthcare by 80.1% during the third quarter. Barclays PLC now owns 122,689 shares of the company's stock valued at $637,000 after buying an additional 54,557 shares during the last quarter. JPMorgan Chase & Co. increased its stake in Aveanna Healthcare by 266.4% during the third quarter. JPMorgan Chase & Co. now owns 85,714 shares of the company's stock valued at $446,000 after acquiring an additional 62,319 shares during the period. SG Americas Securities LLC raised its holdings in Aveanna Healthcare by 26.0% in the 4th quarter. SG Americas Securities LLC now owns 24,366 shares of the company's stock valued at $111,000 after acquiring an additional 5,031 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its position in shares of Aveanna Healthcare by 15.7% in the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 25,171 shares of the company's stock worth $115,000 after acquiring an additional 3,407 shares during the period. Finally, Legato Capital Management LLC acquired a new stake in shares of Aveanna Healthcare during the 4th quarter worth approximately $83,000. Institutional investors own 87.96% of the company's stock.
Analyst Upgrades and Downgrades
A number of research firms recently weighed in on AVAH. Truist Financial lowered their target price on shares of Aveanna Healthcare from $6.00 to $5.50 and set a "hold" rating on the stock in a research note on Friday, April 11th. UBS Group upped their price objective on Aveanna Healthcare from $4.50 to $5.00 and gave the company a "sell" rating in a research note on Friday, May 9th.
View Our Latest Analysis on AVAH
Insider Buying and Selling at Aveanna Healthcare
In related news, major shareholder J.H. Whitney Equity Partners V sold 47,039 shares of the company's stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $5.72, for a total transaction of $269,063.08. Following the transaction, the insider now owns 1,447,191 shares in the company, valued at $8,277,932.52. This represents a 3.15% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, major shareholder Robert M. Williams, Jr. sold 91,061 shares of the business's stock in a transaction dated Thursday, May 8th. The stock was sold at an average price of $5.84, for a total transaction of $531,796.24. Following the completion of the transaction, the insider now directly owns 545,330 shares of the company's stock, valued at approximately $3,184,727.20. This represents a 14.31% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 205,512 shares of company stock worth $1,173,001 over the last ninety days. Corporate insiders own 7.80% of the company's stock.
Aveanna Healthcare Price Performance
Shares of AVAH traded down $0.29 during trading hours on Monday, hitting $5.70. The stock had a trading volume of 2,554,967 shares, compared to its average volume of 293,974. The stock has a market capitalization of $1.11 billion, a price-to-earnings ratio of -16.76 and a beta of 2.01. The company's fifty day moving average is $5.04 and its two-hundred day moving average is $4.92. Aveanna Healthcare Holdings Inc. has a 52 week low of $2.32 and a 52 week high of $6.19.
About Aveanna Healthcare
(
Free Report)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Recommended Stories

Before you consider Aveanna Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.
While Aveanna Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.